7Baggers
Quarterly
Annual
    Unit: USD2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
      
    		                        
      cash flows from operating activities:
    		                        
      net income
    		178,100,000 -5,900,000 232,600,000 94,100,000 83,200,000 50,300,000 26,600,000 21,200,000 20,300,000 8,500,000 22,000,000 56,200,000 9,700,000 31,700,000 74,900,000 -15,800,000 26,200,000 -268,900,000 -3,176,317 2,123,979 2,747,555 2,694,579 2,348,869 2,296,093 
      adjustments to reconcile net income to net cash from operating activities:
    		                        
      depreciation
    		20,100,000 19,800,000 19,700,000 18,900,000 18,000,000 17,700,000 18,700,000 17,800,000 17,600,000 17,900,000 17,500,000 16,400,000 18,300,000 16,900,000 17,400,000 14,400,000 14,300,000 14,200,000       
      amortization
    		48,300,000 48,900,000 49,200,000 49,300,000 49,300,000 48,900,000 51,800,000 57,900,000 59,400,000 61,300,000 52,400,000 35,000,000 35,200,000 35,300,000 35,000,000 35,800,000 35,700,000 36,300,000       
      deferred income taxes
    		4,800,000 -7,600,000 -130,900,000 -2,300,000 -1,800,000 3,400,000 13,400,000 -12,800,000 -4,600,000 -4,600,000 -47,500,000 0 -14,800,000 -7,500,000 6,300,000 -1,800,000 -2,300,000 -3,600,000       
      amortization of debt discount and issuance costs
    		2,000,000 2,100,000 1,600,000 1,600,000 2,000,000 2,700,000 100,000 2,600,000 2,500,000 2,300,000 1,700,000 1,300,000 1,500,000 1,800,000 1,500,000 1,400,000 1,700,000 5,900,000       
      change in fair value of warrant liabilities
    		25,400,000 176,600,000 54,500,000 61,600,000 46,000,000 -4,200,000 33,100,000 9,800,000 -38,900,000 -94,900,000 9,600,000 -32,500,000 71,200,000 13,600,000           
      changes in operating working capital
    		96,100,000 -99,700,000 84,500,000 17,700,000 51,400,000 -86,900,000 -1,200,000 -70,200,000 -261,700,000 -116,100,000 27,200,000 -33,900,000 -81,500,000 -44,600,000 41,300,000 66,500,000 -34,200,000 -134,400,000       
      stock-based compensation
    		8,500,000 9,200,000 6,200,000 6,500,000 6,800,000 5,500,000 4,600,000 6,300,000                 
      other
    		-4,900,000 -5,900,000 38,800,000 1,300,000 -1,300,000 4,600,000 37,300,000 -28,200,000 -7,500,000 -4,500,000 2,700,000 -4,200,000 13,700,000 5,700,000 -15,500,000 26,200,000 19,300,000 -18,200,000       
      net cash from operating activities
    		378,400,000 137,500,000 356,200,000 248,700,000 253,600,000 42,000,000 180,700,000 4,400,000 -205,700,000 -132,200,000 36,500,000 54,400,000 59,300,000 60,700,000 194,500,000 136,100,000 73,000,000 -194,700,000    3,478,760  -587,067 
      cash flows from investing activities:
    		                        
      capital expenditures
    		-34,100,000 -35,800,000 -47,800,000 -26,500,000 -25,800,000 -27,800,000 -38,300,000 -23,500,000 -23,100,000 -15,100,000 -30,100,000 -12,900,000 -13,600,000 -16,800,000 -23,100,000 -8,100,000 -6,500,000 -6,700,000       
      free cash flows
    		344,300,000 101,700,000 308,400,000 222,200,000 227,800,000 14,200,000 142,400,000 -19,100,000 -228,800,000 -147,300,000 6,400,000 41,500,000 45,700,000 43,900,000 171,400,000 128,000,000 66,500,000 -201,400,000       
      investments in capitalized software
    		-10,900,000 -700,000 -3,300,000 -900,000 -500,000 -2,000,000 -3,000,000 -1,300,000 -3,600,000 -3,100,000 -1,700,000 -4,100,000 -4,300,000 -1,100,000 -3,400,000 1,300,000 -4,400,000 -1,800,000       
      proceeds from disposition of property, plant and equipment
    		  0 0 0 12,400,000     3,700,000              
      net cash from investing activities
    		-45,000,000 -36,500,000 -68,000,000 -27,400,000 -26,300,000 -17,400,000 -37,400,000 -24,800,000 -31,700,000 -18,200,000 -1,170,100,000 -10,900,000 -17,900,000 -17,900,000 -19,500,000 -6,800,000 -10,900,000 -8,500,000     0 0 
      cash flows from financing activities:
    		                        
      borrowings from abl revolving credit facility and short-term borrowings
    		80,000,000 190,000,000 300,000 64,900,000 59,500,000 100,200,000 212,400,000 130,800,000 371,800,000 75,800,000               
      repayments of abl revolving credit facility and short-term borrowings
    		-80,000,000 -190,000,000 -300,000 -64,900,000 -284,500,000 -110,200,000 -274,300,000 -26,800,000 -194,700,000 -60,000,000               
      repayment of long-term debt
    		-5,300,000 -5,300,000 -5,300,000 -5,400,000 -5,500,000 -10,900,000 -5,500,000 0 -5,400,000 -5,500,000               
      dividend payment
    		-9,400,000 -9,300,000                       
      repurchase of common stock
    		0 -599,900,000                       
      exercise of employee stock options
    		9,200,000 14,400,000 4,500,000 12,900,000 7,800,000 2,200,000 1,800,000 200,000 100,000 1,000,000 1,500,000 500,000 1,200,000 900,000           
      employee taxes paid from shares withheld
    		-15,000,000 -3,000,000 -500,000 -300,000 -2,400,000 -100,000 0 0   -100,000 -200,000             
      net cash from financing activities
    		-20,500,000 -603,100,000 -10,800,000 7,200,000 -225,100,000 -18,800,000 -144,500,000 91,200,000 155,000,000 -1,500,000 828,400,000 -5,200,000 -11,200,000 102,900,000 28,400,000 -181,200,000 14,200,000 279,300,000     0 -239,163 
      effect of exchange rate changes on cash and cash equivalents
    		-5,700,000 -6,000,000 6,200,000 -3,700,000 -2,800,000 1,800,000 5,700,000 -7,400,000 -8,800,000 1,300,000 700,000 -3,500,000 1,400,000 -3,100,000 6,900,000 4,300,000 200,000 -6,400,000       
      increase in cash, cash equivalents and restricted cash
    		307,200,000 -508,100,000 283,600,000 224,800,000 -600,000 7,600,000 4,500,000 63,400,000 -91,200,000 -150,600,000 -304,500,000 34,800,000 31,600,000 142,600,000 210,300,000 -47,600,000 76,500,000 69,700,000       
      beginning cash, cash equivalents and restricted cash
    		0 788,600,000 0 0 0 273,200,000 0 0 0 447,100,000 0 0 0 542,600,000 0 0 0 233,700,000       
      ending cash, cash equivalents and restricted cash
    		307,200,000 280,500,000 283,600,000 224,800,000 -600,000 280,800,000 4,500,000 63,400,000 -91,200,000 296,500,000 -304,500,000 34,800,000 31,600,000 685,200,000 210,300,000 -47,600,000 76,500,000 303,400,000       
      accounts receivable
    		-125,000,000 9,900,000 -135,800,000 -7,800,000 -32,700,000 -96,200,000 -118,800,000 -87,200,000 -165,000,000 -4,800,000 -49,600,000 -39,400,000 -75,500,000 47,100,000 -38,300,000 -103,700,000         
      inventories
    		-117,600,000 -106,500,000 47,500,000 -5,000,000 -17,000,000 -79,500,000 -9,100,000 -15,200,000 -26,700,000 -160,400,000 22,000,000 -40,400,000 -38,900,000 -68,400,000 26,000,000 2,400,000 -22,400,000 -44,500,000       
      other current assets
    		800,000 -31,700,000  21,100,000 2,500,000 4,900,000 -24,600,000 5,800,000 4,500,000 -14,500,000 -300,000 10,500,000 -2,800,000 -5,300,000 -200,000 9,200,000 -2,600,000 1,400,000       
      accounts payable
    		120,500,000 9,800,000 27,200,000 -8,300,000 25,700,000 -62,300,000 90,600,000 21,600,000 -12,400,000 33,000,000 42,000,000 12,200,000 30,200,000 20,700,000 57,400,000 41,900,000 22,300,000 -43,400,000       
      deferred revenue
    		154,700,000 100,000,000 89,600,000 23,300,000 17,100,000 144,200,000                   
      accrued expenses and other liabilities
    		60,100,000 -68,500,000 46,000,000 18,000,000 44,000,000 -16,500,000 61,300,000 -1,100,000 -45,100,000 30,500,000 6,200,000 21,700,000 25,500,000 -41,500,000 16,100,000 113,200,000 4,300,000 -120,300,000       
      income taxes
    		2,600,000 -12,700,000 38,500,000 -23,600,000 11,800,000 18,500,000 -600,000 5,900,000 -17,000,000 100,000 6,900,000 1,500,000 -20,000,000 2,800,000 -19,700,000 3,500,000 5,200,000 4,200,000       
      total changes in operating working capital
    		96,100,000 -99,700,000 84,500,000 17,700,000 51,400,000 -86,900,000 -1,200,000 -70,200,000 -261,700,000 -116,100,000 27,200,000 -33,900,000 -81,500,000 -44,600,000 41,300,000 66,500,000 -34,200,000 -134,400,000       
      gain on tax receivable agreement
    		                        
      asset impairments
    		                        
      payment of contingent consideration
    		      0 0 0 -8,700,000               
      gain on sale of property, plant and equipment
    		                        
      changes in tax receivable agreement
    		          4,400,000 1,700,000 -200,000 1,800,000           
      acquisition of business
    		                        
      proceeds from sale of business
    		                        
      proceeds from the issuance of long-term debt
    		                        
      payment of debt issuance costs
    		              0          
      payment of tax receivable agreement
    		      -75,000,000 -12,500,000                 
      proceeds from the exercise of warrants
    		          0 0 0 107,500,000           
      supplemental disclosures
    		                        
      cash paid during the year for interest
    		                        
      cash paid during the year for income tax
    		                        
      property and equipment acquired during the year for capital lease obligations
    		                        
      noncash supplemental disclosure
    		                        
      seller provided financing for the disposition of property, plant and equipment
    		                        
      acquisition of business, net of cash acquired
    		      0 0                 
      debt issuance costs
    		                        
      loss on extinguishment of debt
    		          0 0 0 400,000 0 0 0 174,000,000       
      payment of redemption premiums
    		              0 0 0 -75,000,000       
      proceeds from reverse recapitalization
    		              0 0 5,500,000 1,827,000,000       
      payment to vertiv stockholder
    		              0 0 0 -341,600,000       
      other financing
    		              100,000          
      asset impairment
    		                        
      stock based compensation
    		         6,600,000  5,700,000 6,200,000 5,600,000           
      borrowings from abl revolving credit facility
    		              0 0 0 324,200,000       
      repayments of abl revolving credit facility
    		              -100,000,000 -171,400,000 -6,000,000 -193,100,000       
      proceeds from short-term borrowings
    		              0 1,800,000         
      repayment of short-term borrowings
    		              -19,400,000          
      borrowing on term loan, net of discount
    		              0 0 0 2,189,000,000       
      repayment on term loan
    		           -5,500,000 -5,400,000 -5,500,000 -5,500,000 -5,500,000         
      repayment on prior term loan
    		              0 0 0 -2,070,000,000       
      repayment of prior notes
    		              0 0 0 -1,370,000,000       
      capitalized software write-off
    		                        
      gain on sale of business
    		                        
      proceeds from the issuance of 10.00% notes
    		                        
      payment of debt issuance cost
    		                0 -11,200,000       
      accounts receivables
    		                 68,200,000       
      change in operating assets and liabilities:
    		                        
      increase in dividend receivable
    		                  174,890 173,884 75,707 -64,254  -458,769 
      (increase) in prepaid expenses
    		                        
      decrease in receivable from gs dc sponsor i llc
    		                       0 
      increase in accounts payable
    		                  4,828,934 722,807 -260,294 127,569 443,297 74,889 
      increase in accrued tax payable
    		                  -214 0 -810,713 716,488 -617,196 607,423 
      net cash from /(used in) operating activities
    		                        
      proceeds from sponsor commitment
    		                  1,300,000 0     
      proceeds from sale of units in public offering
    		                      0 0 
      proceeds from sale of private placement warrants
    		                      0 0 
      payment of underwriting discounts
    		                      0 0 
      payment of offering costs
    		                      0 -239,163 
      proceeds from gs dc sponsor i llc promissory note
    		                      0 0 
      repayment of gs dc sponsor i llc promissory note
    		                      0 0 
      increase in cash and restricted cash
    		                        
      cash and restricted cash and cash equivalents at beginning of year
    		                        
      cash and restricted cash and cash equivalents at end of year
    		                        
      49
    		                        
      increase in prepaid expenses
    		                        
      decrease in deferred offering costs
    		                   0     
      net cash from / (used in) operating activities
    		                   2,957,563     
      proceeds from sale of class a common stock to public
    		                        
      net cash provided by/ (used in) financing activities
    		                   0     
      increase / (decrease) in cash and restricted cash
    		                   2,957,563     
      cash and restricted cash and cash equivalents, at beginning of period
    		                   0     
      cash and restricted cash and cash equivalents, at end of period
    		                   2,957,563     
      item 2.
    		                        
      decrease in prepaid expenses
    		                    46,340 4,378   
      increase in deferred tax receivable
    		                        
      increase / (decrease) in cash and restricted cash and cash equivalents
    		                     3,478,760   
      cash and restricted cash and cash equivalents at beginning of period
    		                     695,718,681   
      cash and restricted cash and cash equivalents at end of period
    		                     699,197,441   
      dividend earned on investments held in trust account
    		                        
      (increase) in dividend receivable
    		                        
      increase in receivable from gs dc sponsor i llc
    		                        
      professional fees paid by gs sponsor llc on behalf of the company
    		                        
      proceeds deposited into trust account
    		                      0 0 
      proceeds from sale of class b common stock to gs sponsor llc
    		                        
      increase in cash
    		                      -149,379 -826,230 
      cash at beginning of year
    		                        
      cash at end of year
    		                        
      supplemental disclosure of cash flow information:
    		                        
      cash paid out of trust account during the year for income taxes
    		                        
      supplemental disclosure of non-cash financing activities:
    		                        
      accrued offering costs
    		                      0 -154,163 
      deferred underwriting compensation
    		                      0 0 
      2018
    		                        
      general and administrative expenses
    		                        
      basic and diluted earning (loss) available to class a common stock
    		                        
      basic and diluted earning (loss) available to class b common stock
    		                        
      2017
    		                        
      interest earned on investments held in trust account
    		                        
      cash at beginning of period
    		                        
      cash at end of period
    		                       -826,230 
      supplemental disclosure of non-cash financing activities
    		                        
      no.
    		                        
      31.1*
    		                        
      32.1**
    		                        
      101.ins*
    		                        
      101.sch*
    		                        
      101.cal*
    		                        
      101.def*
    		                        
      101.lab*
    		                        
      101.pre*
    		                        
      3.1
    		                        
      4.4
    		                        
      10.1
    		                        
      10.2
    		                        
      10.3
    		                        
      10.4
    		                        
      10.5
    		                        
      10.6
    		                        
      10.7
    		                        
      10.8
    		                        
      10.9
    		                        
      10.10
    		                        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.